Your browser doesn't support javascript.
loading
A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer.
Kelly, R J; Shepherd, F A; Krivoshik, A; Jie, F; Horn, L.
Affiliation
  • Kelly RJ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore and The Charles A. Sammons Cancer Center at Baylor University Medical Center, Dallas, USA. Electronic address: Ronan.Kelly@BSWHealth.org.
  • Shepherd FA; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Krivoshik A; Departments of Oncology.
  • Jie F; Biostatistics, Astellas Pharma US, Inc., Northbrook.
  • Horn L; Department of Medicine, Vanderbilt University Medical Center, Nashville, USA.
Ann Oncol ; 30(7): 1127-1133, 2019 07 01.
Article in En | MEDLINE | ID: mdl-31070709
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Piperidines / Pyrazines / Pyrrolidines / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Piperidines / Pyrazines / Pyrrolidines / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: Reino Unido